These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35084654)

  • 1. Cortical Dysplasia in Rats Provokes Neurovascular Alterations, GLUT1 Dysfunction, and Metabolic Disturbances That Are Sustained Post-Seizure Induction.
    Ghosh C; Myers R; O'Connor C; Williams S; Liu X; Hossain M; Nemeth M; Najm IM
    Mol Neurobiol; 2022 Apr; 59(4):2389-2406. PubMed ID: 35084654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTOR is involved in stroke-induced seizures and the anti-seizure effect of mild hypothermia.
    Yang GS; Zhou XY; An XF; Liu XJ; Zhang YJ; Yu D
    Mol Med Rep; 2018 Apr; 17(4):5821-5829. PubMed ID: 29484389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-brain barrier, epileptogenesis, and treatment strategies in cortical dysplasia.
    Kaya M; Becker AJ; Gürses C
    Epilepsia; 2012 Nov; 53 Suppl 6():31-6. PubMed ID: 23134493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NPRL3 loss alters neuronal morphology, mTOR localization, cortical lamination and seizure threshold.
    Iffland PH; Everett ME; Cobb-Pitstick KM; Bowser LE; Barnes AE; Babus JK; Romanowski AJ; Baybis M; Elziny S; Puffenberger EG; Gonzaga-Jauregui C; Poulopoulos A; Carson VJ; Crino PB
    Brain; 2022 Nov; 145(11):3872-3885. PubMed ID: 35136953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-seizure gene therapy for focal cortical dysplasia.
    Almacellas Barbanoj A; Graham RT; Maffei B; Carpenter JC; Leite M; Hoke J; Hardjo F; Scott-Solache J; Chimonides C; Schorge S; Kullmann DM; Magloire V; Lignani G
    Brain; 2024 Feb; 147(2):542-553. PubMed ID: 38100333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate reduces blood-brain barrier disruption and inhibits seizure activity in hyperthermia-induced seizures in rats with cortical dysplasia.
    Gürses C; Orhan N; Ahishali B; Yilmaz CU; Kemikler G; Elmas I; Cevik A; Kucuk M; Arican N; Kaya M
    Brain Res; 2013 Feb; 1494():91-100. PubMed ID: 23201444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformations.
    Wong M
    Exp Neurol; 2013 Jun; 244():22-6. PubMed ID: 22015915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia.
    Nguyen LH; Brewster AL; Clark ME; Regnier-Golanov A; Sunnen CN; Patil VV; D'Arcangelo G; Anderson AE
    Epilepsia; 2015 Apr; 56(4):636-46. PubMed ID: 25752454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the Mammalian Target of Rapamycin for Epileptic Encephalopathies and Malformations of Cortical Development.
    Jeong A; Wong M
    J Child Neurol; 2018 Jan; 33(1):55-63. PubMed ID: 29246093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological and functional changes of blood-brain barrier in kindled rats with cortical dysplasia.
    Kaya M; Gurses C; Kalayci R; Ekizoglu O; Ahishali B; Orhan N; Oku B; Arican N; Ustek D; Bilgic B; Elmas I; Kucuk M; Kemikler G
    Brain Res; 2008 May; 1208():181-91. PubMed ID: 18395195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.
    Lee WS; Baldassari S; Stephenson SEM; Lockhart PJ; Baulac S; Leventer RJ
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vagus nerve stimulation inhibits seizure activity and protects blood-brain barrier integrity in kindled rats with cortical dysplasia.
    Kaya M; Orhan N; Karabacak E; Bahceci MB; Arican N; Ahishali B; Kemikler G; Uslu A; Cevik A; Yilmaz CU; Kucuk M; Gürses C
    Life Sci; 2013 Mar; 92(4-5):289-97. PubMed ID: 23333826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single injection of a low dose of pentylenetetrazole leads to epileptogenesis in an animal model of cortical dysplasia.
    Oghlakian RO; Tilelli CQ; Hiremath GK; Alexopoulos AV; Najm IM
    Epilepsia; 2009 Apr; 50(4):801-10. PubMed ID: 19396951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation.
    van Vliet EA; Forte G; Holtman L; den Burger JC; Sinjewel A; de Vries HE; Aronica E; Gorter JA
    Epilepsia; 2012 Jul; 53(7):1254-63. PubMed ID: 22612226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurovascular Drug Biotransformation Machinery in Focal Human Epilepsies: Brain CYP3A4 Correlates with Seizure Frequency and Antiepileptic Drug Therapy.
    Williams S; Hossain M; Ferguson L; Busch RM; Marchi N; Gonzalez-Martinez J; Perucca E; Najm IM; Ghosh C
    Mol Neurobiol; 2019 Dec; 56(12):8392-8407. PubMed ID: 31243719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam decreases the seizure activity and blood-brain barrier permeability in pentylenetetrazole-kindled rats with cortical dysplasia.
    Gurses C; Ekizoglu O; Orhan N; Ustek D; Arican N; Ahishali B; Elmas I; Kucuk M; Bilgic B; Kemikler G; Kalayci R; Karadeniz A; Kaya M
    Brain Res; 2009 Jul; 1281():71-83. PubMed ID: 19464270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mouse model of DEPDC5-related epilepsy: Neuronal loss of Depdc5 causes dysplastic and ectopic neurons, increased mTOR signaling, and seizure susceptibility.
    Yuskaitis CJ; Jones BM; Wolfson RL; Super CE; Dhamne SC; Rotenberg A; Sabatini DM; Sahin M; Poduri A
    Neurobiol Dis; 2018 Mar; 111():91-101. PubMed ID: 29274432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis.
    Yasin SA; Ali AM; Tata M; Picker SR; Anderson GW; Latimer-Bowman E; Nicholson SL; Harkness W; Cross JH; Paine SM; Jacques TS
    Acta Neuropathol; 2013 Aug; 126(2):207-18. PubMed ID: 23728790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the GLUT1 Glucose Transporter in Postnatal CNS Angiogenesis and Blood-Brain Barrier Integrity.
    Veys K; Fan Z; Ghobrial M; Bouché A; García-Caballero M; Vriens K; Conchinha NV; Seuwen A; Schlegel F; Gorski T; Crabbé M; Gilardoni P; Ardicoglu R; Schaffenrath J; Casteels C; De Smet G; Smolders I; Van Laere K; Abel ED; Fendt SM; Schroeter A; Kalucka J; Cantelmo AR; Wälchli T; Keller A; Carmeliet P; De Bock K
    Circ Res; 2020 Jul; 127(4):466-482. PubMed ID: 32404031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.